Published in Peptides on March 01, 2003
[The binding of Semax, ACTH 4-10 heptapeptide, to plasma membranes of the rat forebrain basal nuclei and its biodegradation]. Bioorg Khim (2004) 1.61
[Kinetics of Semax penetration into the brain and blood of rats after its intranasal administration]. Bioorg Khim (2006) 1.56
Transportability and reproducibility of the AST/ALT ratio in chronic hepatitis C patients. Am J Gastroenterol (2001) 1.44
Evidence of cholecystokinin release by bombesin in the dog. Br J Pharmacol (1974) 1.37
Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Ann Rheum Dis (2007) 1.26
Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin. Br J Pharmacol (1981) 1.24
Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem (2001) 1.22
Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. J Hepatol (2000) 1.16
[A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)]. Zh Vyssh Nerv Deiat Im I P Pavlova (1997) 1.15
Entry of the synthetic ACTH(4-10) analogue into the rat brain following intravenous injection. Neurosci Lett (1991) 1.10
Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury. Circ Res (1985) 1.09
[Evenly tritium-labeled peptides and their in vivo and in vitro biodegradation]. Bioorg Khim (2006) 1.07
Effects of bombesin and bombesin-like peptides on gastrointestinal myoelectric activity. Gastroenterology (1975) 1.06
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. Dig Liver Dis (2004) 1.06
Natural and hybrid ("chimeric") stable regulatory glyproline peptides. Pathophysiology (2005) 1.05
Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain. J Cell Sci (1997) 1.05
The heptapeptide SEMAX stimulates BDNF expression in different areas of the rat brain in vivo. Dokl Biol Sci (2003) 1.04
Abnormal platelet glutamate dehydrogenase activity and activation in dominant and nondominant olivopontocerebellar atrophy. Ann Neurol (1986) 1.03
[Effect of insulin on the myocardium of the active, hibernating and wakening ground squirrel Citellus undulatus]. Biofizika (2000) 1.03
Rapid induction of neurotrophin mRNAs in rat glial cell cultures by Semax, an adrenocorticotropic hormone analog. Neurosci Lett (2001) 1.02
[Proteolysis of semax analogues with different N-terminal amino acids by aminopeptidases]. Bioorg Khim (2011) 0.99
[Characteristics of force-frequency relations in the myocardium of the squirrel Citellus undulatus]. Biofizika (2002) 0.99
[Effect of modification of the N-terminal region of molecule on the expression of neotropic effect of semax analogues]. Izv Akad Nauk Ser Biol (2005) 0.95
[Effects of chronic Semax administration on exploratory activity and emotional reaction in white rats]. Ross Fiziol Zh Im I M Sechenova (2007) 0.94
The combined antidiabetogenic and anticoagulation effecta of tripeptide Gly-Pro-Arg as estimated in the model of persistent hyperglycemia in rats. Dokl Biol Sci (2011) 0.94
Parallel bioassay of bombesin and litorin, a bombesin-like peptide from the skin of Litoria aurea. Br J Pharmacol (1975) 0.94
Ex vivo screening of prospective peptide drugs: new approaches. Dokl Biol Sci (2010) 0.94
In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions. Br J Pharmacol (2009) 0.92
Central effect of SNC 80, a selective and systemically active delta-opioid receptor agonist, on gastrointestinal propulsion in the mouse. Eur J Pharmacol (1998) 0.90
[Immunomodulatory effects of selank in patients with anxiety-asthenic disorders]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.90
Comparison of pharmacokinetics and metabolism of Pro-Gly-Pro-Leu administered intranasally and intravenously in the blood and brain of rats. Dokl Biochem Biophys (2014) 0.90
Poly (ADP-ribose) polymerase 1 protein expression in normal and neoplastic prostatic tissue. Eur J Histochem (2013) 0.89
Can the MEGX test and serum bile acids improve the prognostic ability of Child-Pugh's score in liver cirrhosis? Eur J Gastroenterol Hepatol (1999) 0.89
IL-4 promotes the migration of circulating B cells to the spleen and increases splenic B cell survival. J Immunol (2000) 0.89
Steatosis in chronic hepatitis C: can weight reduction improve therapeutic efficacy? J Hepatol (2001) 0.88
Specific binding of semax in different regions of the rat brain. Dokl Biol Sci (2007) 0.87
[Structural-functional study of glycine-and-proline-containing peptides (glyprolines) as potential neuroprotectors]. Bioorg Khim (2009) 0.87
Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment. Aliment Pharmacol Ther (2003) 0.86
Binding of tripeptide Pro-Gly-Pro labeled at the C-terminal proline residue to plasma membranes of the rat forebrain. Dokl Biol Sci (2008) 0.86
Antiviral properties of structural fragments of the peptide Selank. Dokl Biol Sci (2010) 0.85
Semax prevents functional impairments of avoidance response in rats. Dokl Biol Sci (2013) 0.85
TLQP-21, a VGF-derived peptide, stimulates exocrine pancreatic secretion in the rat. Peptides (2012) 0.84
Imaging the essential role of spin fluctuations in high-T(c) superconductivity. Phys Rev Lett (2009) 0.83
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? Ann Ig (2004) 0.83
Tauroursodeoxycholic acid administration as adjuvant therapy in cirrhotic patients on transplantation waiting lists. Hepatogastroenterology (2001) 0.82
The solid-state catalytic synthesis of tritium labeled amino acids, peptides and proteins. Amino Acids (1995) 0.82
Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease. Am J Gastroenterol (1997) 0.82
Low frequency of hCDC4 mutations in human primary ovarian cancer. Gynecol Oncol (2007) 0.82
Characteristic features of specific binding of pentapeptide HFPGP labeled at the C-terminal proline residue to rat forebrain plasma membranes. Dokl Biochem Biophys (2014) 0.82
Distribution and metabolism of dermorphin in rats. Pharmacol Res Commun (1984) 0.81
Neurotrophin gene expression in rat brain under the action of Semax, an analogue of ACTH 4-10. Neurosci Lett (2007) 0.81
[Effect of structural changes of Pro6 in dermorphin molecule on its antinociceptive activity]. Izv Akad Nauk Ser Biol (2002) 0.81
Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis. Neurogastroenterol Motil (2010) 0.81
External pancreatic secretion after bombesin infusion in man. Gut (1975) 0.81
Phagocyte chemoattractant receptors. Ann N Y Acad Sci (1997) 0.81
The effect of α-melanocyte-stimulating hormone on early stages of differentiation of mouse embryonic stem cells. Dokl Biol Sci (2013) 0.81
The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system. Neurosci Behav Physiol (2004) 0.81
[Long-lasting behavioral effects of chronic neonatal treatment with ACTH (4-10) analogue semax in white rat pups]. Zh Vyssh Nerv Deiat Im I P Pavlova (2005) 0.81
[Changes in beta-casomorphine-7 effect on behavior of albino rat pups in postnatal development]. Zh Vyssh Nerv Deiat Im I P Pavlova (2001) 0.81
Degradation of the ACTH(4-10) analog Semax in the presence of rat basal forebrain cell cultures and plasma membranes. Amino Acids (2006) 0.80
Expression changes caused by the peptide semax in the intracellular signal pathway genes in rat hippocamp. Dokl Biochem Biophys (2008) 0.80
Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex. Bull Exp Biol Med (2006) 0.80
Antidiarrheal and colonic antipropulsive effects of spinal and supraspinal administration of the natural delta opioid receptor agonist, [D-Ala2]deltorphin II, in the rat. Eur J Pharmacol (1992) 0.80
Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio index. J Intern Med (2006) 0.80
Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion. Pharmacol Res (2008) 0.80
The effect of semax on animal pain sensitivity in various experimental models. Dokl Biol Sci (2003) 0.80
[The role of opioid system in peculiarities of anti-anxiety effect of peptide anxiolytic selank]. Eksp Klin Farmakol (2012) 0.79
The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions. Peptides (2005) 0.79
Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding. Br J Pharmacol (1995) 0.79
Effect of glyprolines PGP, GP, and PG on homeostasis of gastric mucosa in rats with experimental ethanol-induced gastric ulcers. Bull Exp Biol Med (2010) 0.79
Effects of dietary carbohydrates on body lipid composition and on some enzymatic activities in the rat. Nutr Metab (1970) 0.79
[Analgesic activity of dipeptide Tyr-Pro]. Izv Akad Nauk Ser Biol (2008) 0.78
Use of Selank to correct measures of integrative brain activity and biogenic amine levels in adult rats resulting from antenatal hypoxia. Neurosci Behav Physiol (2008) 0.78
Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis. Hepatogastroenterology (1998) 0.78
Effect of glyprolines on homeostasis of gastric mucosa in rats with stress ulcers. Bull Exp Biol Med (2010) 0.78
Leptin in nonalcoholic steatohepatitis: is it one of the "hits"? Am J Gastroenterol (2001) 0.78
Naloxone-blocked depriming effect of anxiolytic selank on apomorphine-induced behavioral manifestations of hyperfunction of dopamine system. Bull Exp Biol Med (2006) 0.78
HS-599: a novel long acting opioid analgesic does not induce place-preference in rats. Br J Pharmacol (2001) 0.78
[Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. Bioorg Khim (2001) 0.78
Pituitary-adrenal and vagus modulation of sauvagine- and CRF-induced inhibition of gastric emptying in rats. Eur J Pharmacol (1990) 0.78
Infrared conductivity of elemental bismuth under pressure: evidence for an avoided Lifshitz-type semimetal-semiconductor transition. Phys Rev Lett (2010) 0.77
Charge carrier interaction with a purely electronic collective mode: plasmarons and the infrared response of elemental bismuth. Phys Rev Lett (2007) 0.77
Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII. Eur J Pharmacol (1999) 0.77
Central and peripheral role of the nociceptin/orphaninFQ system on normal and disturbed colonic motor function and faecal pellet output in the rat. Neurogastroenterol Motil (2008) 0.77
Transcriptomic response of rat hippocampus and spleen cells to single and chronic administration of the peptide selank. Dokl Biochem Biophys (2010) 0.77